One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases

被引:11
|
作者
Van Voorhis, Wesley C. [1 ]
Hulverson, Matthew A. [1 ]
Choi, Ryan [1 ]
Huang, Wenlin [2 ]
Arnold, Samuel L. M. [1 ]
Schaefer, Deborah A. [3 ]
Betzer, Dana P. [5 ]
Vidadala, Rama S. R. [4 ]
Lee, Sangun [6 ]
Whitman, Grant R. [1 ]
Barrett, Lynn K. [1 ]
Maly, Dustin J. [4 ]
Riggs, Michael W. [3 ]
Fan, Erkang [2 ]
Kennedy, Thomas J. [5 ]
Tzipori, Saul [6 ]
Doggett, J. Stone [7 ]
Winzer, Pablo [8 ]
Anghel, Nicoleta [8 ]
Imhof, Dennis [2 ]
Muller, Joachim [8 ]
Hemphill, Andrew [8 ]
Ferre, Ignacio [9 ]
Sanchez-Sanchez, Roberto [9 ]
Ortega-Mora, Luis Miguel [9 ]
Ojo, Kayode K. [1 ]
机构
[1] Univ Washington, Dept Med, Div Allergy & Infect Dis, Ctr Emerging & Re Emerging Infect Dis CERID, Seattle, WA 98109 USA
[2] Univ Washington, Dept Biochem, Seattle, WA 98195 USA
[3] Univ Arizona, Sch Anim & Comparat Biomed Sci, Tucson, AZ 85721 USA
[4] Univ Washington, Dept Chem, Seattle, WA 98195 USA
[5] Eleven Bravo LLC, Westport, WI 53597 USA
[6] Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA 01536 USA
[7] Oregon Hlth & Sci Univ, Portland, OR 97239 USA
[8] Univ Bern, Vetsuisse Fac, Inst Parasitol, Dept Infect Dis & Pathobiol, CH-3012 Bern, Switzerland
[9] Univ Complutense Madrid, Fac Vet Sci, Anim Hlth Dept, Saluvet, Ciudad Univ S-N, Madrid 28040, Spain
基金
美国食品与农业研究所; 比尔及梅琳达.盖茨基金会; 瑞士国家科学基金会; 美国国家卫生研究院;
关键词
Antiparastics; Apicomplexa; Kinase inhibitors; BUMPED-KINASE INHIBITORS; TOXOPLASMA-GONDII; SELECTIVE INHIBITORS; NEOSPORA-CANINUM; PROTEIN-KINASES; C; PARVUM; IN-VITRO; POTENT; CHILDREN; EFFICACY;
D O I
10.1016/j.vetpar.2020.109336
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
This is a review of the development of bumped-kinase inhibitors (BKIs) for the therapy of One Health parasitic apicomplexan diseases. Many apicomplexan infections are shared between humans and livestock, such as cryptosporidiosis and toxoplasmosis, as well as livestock only diseases such as neospomsis. We have demon-strated proof-of-concept for BKI therapy in livestock models of cryptosporidiosis (newborn calves infected with Cryptosporidium parvum), toxoplasmosis (pregnant sheep infected with Toxoplasma gondii), and neosporosis (pregnant sheep infected with Neospora caninum). We discuss the potential uses of BKIs for the treatment of diseases caused by apicomplexan parasites in animals and humans, and the improvements that need to be made to further develop BKIs.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development
    Wan, Qianya
    Song, Dan
    Li, Huangcan
    He, Ming-liang
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [32] Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development
    Qianya Wan
    Dan Song
    Huangcan Li
    Ming-liang He
    Signal Transduction and Targeted Therapy, 5
  • [33] Bridging the gap between target-based and phenotypic-based drug discovery
    Calado, Cecilia R. C.
    EXPERT OPINION ON DRUG DISCOVERY, 2024, 19 (07) : 789 - 798
  • [34] Analysis of a Drug Target-Based Classification System Using Molecular Descriptors
    Lu, Jing
    Zhang, Pin
    Bi, Yi
    Luo, Xiaomin
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2016, 19 (02) : 129 - 135
  • [35] An in Silico Approach for Integrating Phenotypic and Target-Based Approaches in Drug Discovery
    Iwata, Hiroaki
    Kojima, Ryosuke
    Okuno, Yasushi
    MOLECULAR INFORMATICS, 2020, 39 (1-2)
  • [36] Triazole-fused pyrimidines in target-based anticancer drug discovery
    Dai, Xing-Jie
    Xue, Lei-Peng
    Ji, Shi-Kun
    Zhou, Ying
    Gao, Ya
    Zheng, Yi-Chao
    Liu, Hui-Min
    Liu, Hong-Min
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 249
  • [37] Drug Discovery in the Age of Artificial Intelligence: Transformative Target-Based Approaches
    Patne, Akshata Yashwant
    Dhulipala, Sai Madhav
    Lawless, William
    Prakash, Satya
    Mohapatra, Shyam S.
    Mohapatra, Subhra
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (22)
  • [38] Reductionism and proxy failure: From neuroscience to target-based drug discovery
    Sadri, Arash
    Paknezhad, Sepideh
    BEHAVIORAL AND BRAIN SCIENCES, 2024, 47
  • [39] Target-Based Evaluation of "Drug-Like" Properties and Ligand Efficiencies
    Leeson, Paul D.
    Bento, A. Patricia
    Gaulton, Anna
    Hersey, Anne
    Manners, Emma J.
    Radoux, Chris J.
    Leach, Andrew R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (11) : 7210 - 7230
  • [40] Use of genomic signatures in therapeutics development in oncology and other diseases
    Simon, R.
    Wang, S-J
    PHARMACOGENOMICS JOURNAL, 2006, 6 (03): : 166 - 173